The Interaction Between Orientin and the Spike of SARS-CoV-2: An In Silico and Experimental Approach
Viruses · 2025
DOI: 10.3390/v18010061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Gabriel Cavalcante Pacheco und 3 weiteren Autor:innen. Beteiligte Einrichtung: Núcleo Multidisciplinar de Pesquisa em Biologia-NUMPEX-BIO, Campus Duque de Caxias Professor Geraldo Cidade, Universidade Federal do Rio de Janeiro, …. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Glucosides, SARS-CoV-2, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à pesquisa do estado do Rio de Janeiro, Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro—FAPERJ.
Abstract (Originalsprache)
SARS-CoV-2, the causative agent of COVID-19, has led to over seven million deaths worldwide prior to May 2025. Despite widespread vaccination programs, COVID-19 remains a persistent global health challenge, underscoring the urgent need for new therapeutic approaches. Orientin is a flavonoid with reported antiviral activity, though its potential against SARS-CoV-2 remains poorly explored. This study aimed to investigate whether Orientin interacts with the viral Spike protein and impacts viral replication. Molecular docking simulations using DockThor were employed to predict the binding affinity between Orientin and the receptor-binding domain (RBD) of the Spike protein. Fluorescence spectroscopy assays were performed to assess direct interactions between Orientin and the trimeric form of the Spike protein. Additionally, cytotoxicity and viral replication assays were carried out in Vero cells to evaluate Orientin’s antiviral effects. Docking results indicated that Orientin likely binds to key RBD residues involved in ACE2 receptor recognition. Spectroscopic analyses showed a decrease in intrinsic tryptophan fluorescence, suggesting direct interaction. Orientin demonstrated no cytotoxicity in Vero cells and exhibited moderate inhibition of viral replication. These findings suggest that Orientin interacts with critical regions of the Spike protein and may act as a moderate in vitro inhibitor of SARS-CoV-2, warranting further investigation into its therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Núcleo Multidisciplinar de Pesquisa em Biologia-NUMPEX-BIO, Campus Duque de Caxias Professor Geraldo Cidade, Universidade Federal do Rio de Janeiro, Rio de Janeiro 25240-005, Brazil.
- Laboratório de Ultraestrutura Celular Herta Meyer, Centro de Pesquisa em Medicina de Precisão, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-853, Brazil.
- Núcleo Multidisciplinar de Pesquisa em Computação-Numpex-COMP, Campus Duque de Caxias Professor Geraldo Cidade, Universidade Federal do Rio de Janeiro, Rio de Janeiro 25240-005, Brazil.
ORCID-Profile: Gabriel Cavalcante Pacheco, Michele de Sá Ribeiro, Camila Silva de Magalhães, Fabiana Avila Carneiro
Förderung
- Fundação de Amparo à pesquisa do estado do Rio de Janeiro
- Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro—FAPERJ
Zitieren
APA
Pacheco, G. C., Ribeiro, M. S., de Magalhães, C. S., & Carneiro, F. A. (2025). The Interaction Between Orientin and the Spike of SARS-CoV-2: An In Silico and Experimental Approach. Viruses. https://doi.org/10.3390/v18010061
Vancouver
Pacheco GC, Ribeiro MS, de Magalhães CS, Carneiro FA. The Interaction Between Orientin and the Spike of SARS-CoV-2: An In Silico and Experimental Approach. Viruses. 2025. doi:10.3390/v18010061
BibTeX
@article{Pacheco2025,
author = {Pacheco, Gabriel Cavalcante and Ribeiro, Michele de Sá and de Magalhães, Camila Silva and Carneiro, Fabiana Avila},
title = {The Interaction Between Orientin and the Spike of SARS-CoV-2: An In Silico and Experimental Approach},
journal = {Viruses},
year = {2025},
doi = {10.3390/v18010061}
}
EUVIMED